New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
How personalization and machine learning can improve cancer outreach ROI

How personalization and machine learning can improve cancer outreach ROI

by Matt Weingarden,American Marketing AssociationCredit: CC0 Public DomainResearchers from Texas A&M, Iowa State University, Rice, and University of Texas Southwestern Medical Center publish
World medicine December 09,2023
How personalization and machine learning can improve cancer outreach ROI

How personalization and machine learning can improve cancer outreach ROI

by Matt Weingarden,American Marketing AssociationCredit: CC0 Public DomainResearchers from Texas A&M, Iowa State University, Rice, and University of Texas Southwestern Medical Center publish
World medicine December 09,2023
Missing BAP1 gene associated with immunosuppressive molecules in uveal melanoma

Missing BAP1 gene associated with immunosuppressive molecules in uveal melanoma

byUniversity of TurkuCredit: University of TurkuImmunotherapies using immune checkpoint inhibitors (ICI) have dramatically improved cancer survival in the last decade, resulting in the Nobel Pri
World medicine December 09,2023
Missing BAP1 gene associated with immunosuppressive molecules in uveal melanoma

Missing BAP1 gene associated with immunosuppressive molecules in uveal melanoma

byUniversity of TurkuCredit: University of TurkuImmunotherapies using immune checkpoint inhibitors (ICI) have dramatically improved cancer survival in the last decade, resulting in the Nobel Pri
World medicine December 09,2023
New type of immunotherapy hinders the spread of ovarian cancer

New type of immunotherapy hinders the spread of ovarian cancer

byAarhus UniversityCredit: CC0 Public DomainMalignant ovarian cancer is insidious: Known and feared for vague and uncharacteristic symptoms that often mean the disease is discovered so late that
World medicine December 09,2023
New type of immunotherapy hinders the spread of ovarian cancer

New type of immunotherapy hinders the spread of ovarian cancer

byAarhus UniversityCredit: CC0 Public DomainMalignant ovarian cancer is insidious: Known and feared for vague and uncharacteristic symptoms that often mean the disease is discovered so late that
World medicine December 09,2023
AI may help predict responses to non-small cell lung cancer systemic therapies

AI may help predict responses to non-small cell lung cancer systemic therapies

byAmerican Association for Cancer ResearchCredit: CC0 Public DomainUsing standard-of-care computed tomography (CT) scans in patients with advanced non-small cell lung cancer (NSCLC), researchers
World medicine December 09,2023
AI may help predict responses to non-small cell lung cancer systemic therapies

AI may help predict responses to non-small cell lung cancer systemic therapies

byAmerican Association for Cancer ResearchCredit: CC0 Public DomainUsing standard-of-care computed tomography (CT) scans in patients with advanced non-small cell lung cancer (NSCLC), researchers
World medicine December 09,2023
Androgen receptor stops tumor growth in the most common form of breast cancer

Androgen receptor stops tumor growth in the most common form of breast cancer

byThe Endocrine SocietyCredit: CC0 Public DomainResearchers say they have found a viable new therapeutic strategy for estrogen receptor-positive (ER+) breast cancer, even cancers that are resist
World medicine December 09,2023
Androgen receptor stops tumor growth in the most common form of breast cancer

Androgen receptor stops tumor growth in the most common form of breast cancer

byThe Endocrine SocietyCredit: CC0 Public DomainResearchers say they have found a viable new therapeutic strategy for estrogen receptor-positive (ER+) breast cancer, even cancers that are resist
World medicine December 09,2023
Women's wellness: Sexual health after cancer treatment

Women's wellness: Sexual health after cancer treatment

by From Mayo Clinic News NetworkCredit: CC0 Public DomainFollowing a cancer diagnosis, patients often ask many questions about their treatment and possible side effects. One area that is often overloo
World medicine December 09,2023
Women's wellness: Sexual health after cancer treatment

Women's wellness: Sexual health after cancer treatment

by From Mayo Clinic News NetworkCredit: CC0 Public DomainFollowing a cancer diagnosis, patients often ask many questions about their treatment and possible side effects. One area that is often overloo
World medicine December 09,2023
New study suggests weight gain may reduce breast cancer risk

New study suggests weight gain may reduce breast cancer risk

by Crystal VillarrealCredit: CC0 Public DomainA recent study published in theInternational Journal of Cancer, has found that women who gain weight from early adulthood are at a reduced risk of d
World medicine December 09,2023
New study suggests weight gain may reduce breast cancer risk

New study suggests weight gain may reduce breast cancer risk

by Crystal VillarrealCredit: CC0 Public DomainA recent study published in theInternational Journal of Cancer, has found that women who gain weight from early adulthood are at a reduced risk of d
World medicine December 09,2023
Fiber consumption linked to lower breast cancer risk

Fiber consumption linked to lower breast cancer risk

byWileyMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainConsuming a diet high in fiber was linked with a reduced incidence of breast cancer in an
World medicine December 09,2023
Fiber consumption linked to lower breast cancer risk

Fiber consumption linked to lower breast cancer risk

byWileyMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainConsuming a diet high in fiber was linked with a reduced incidence of breast cancer in an
World medicine December 09,2023
HER2-targeted therapy trastuzumab deruxtecan shows early promise in patients with non-breast and non-gastric cancers

HER2-targeted therapy trastuzumab deruxtecan shows early promise in patients with non-breast and non-gastric cancers

byAmerican Association for Cancer ResearchA HER2-targeted antibody-drug conjugate, fam-trastuzumab deruxtecan-nxki (Enhertu), showed signs of clinical activity in multiple non-breast/non-gastric
World medicine December 09,2023
HER2-targeted therapy trastuzumab deruxtecan shows early promise in patients with non-breast and non-gastric cancers

HER2-targeted therapy trastuzumab deruxtecan shows early promise in patients with non-breast and non-gastric cancers

byAmerican Association for Cancer ResearchA HER2-targeted antibody-drug conjugate, fam-trastuzumab deruxtecan-nxki (Enhertu), showed signs of clinical activity in multiple non-breast/non-gastric
World medicine December 09,2023
In NIH trial, selumetinib shrinks tumors, provides clinical benefit for children with NF1

In NIH trial, selumetinib shrinks tumors, provides clinical benefit for children with NF1

byNational Cancer InstituteFindings from a phase 2 clinical trial show that the drug selumetinib improves outcomes for children with the genetic disorder neurofibromatosis type 1 (NF1). In the t
World medicine December 09,2023
In NIH trial, selumetinib shrinks tumors, provides clinical benefit for children with NF1

In NIH trial, selumetinib shrinks tumors, provides clinical benefit for children with NF1

byNational Cancer InstituteFindings from a phase 2 clinical trial show that the drug selumetinib improves outcomes for children with the genetic disorder neurofibromatosis type 1 (NF1). In the t
World medicine December 09,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com